Efficacy and cost of high-frequency IGRT in elderly stage III non-small-cell lung cancer patients.

Efficacy and cost of high-frequency IGRT in elderly stage III non-small-cell lung cancer patients.

<h4>Background</h4>High-frequency image-guided radiotherapy (hfIGRT) is ubiquitous but its benefits are unproven. We examined the cost effectiveness of hfIGRT in stage III non-small-cell lung cancer (NSCLC).<h4>Methods</h4>We selected stage III NSCLC patients ≥66 years old wh...

Full description

Bibliographic Details
Main Authors: Samuel P Heilbroner, Eric P Xanthopoulos, Donna Buono, Daniel Carrier, Ben Y Durkee, Michael Corradetti, Tony J C Wang, Alfred I Neugut, Dawn L Hershman, Simon K Cheng
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0252053

Internet

https://doi.org/10.1371/journal.pone.0252053

Similar Items